Join

or

Existing user? Login

Call for submissions on polypharmacy and medicines optimisation

Clinical Pharmacist today invites article submissions to showcase current and best practice in the area of polypharmacy and medicines optimisation.

This area is an increasing policy focus around the world, with the World Health Organization aiming to reduce severe avoidable medication related harm by 50% globally over five years since 2017[1].

In the UK, around half of people aged 75 years take five or more medicines, and avoidable adverse drug reactions cause an estimated 712 deaths each year[2],[3].

Articles covering the following topics are of particular interest:

  • Evidence of current best practice and management of patients across all sectors (primary, secondary and care homes) relating to both ‘appropriate’ and ‘inappropriate’ polypharmacy;
  • Innovative policies or schemes that seek to reduce patient harm from polypharmacy or medication errors;
  • The use of tools and technologies to improve medication use or reduce harm;
  • Schemes that aim to increase patient activation and/or knowledge about their medicines;
  • Demonstration of the impact of pharmacists and pharmacy professionals in preventing medicines-related harm and/or deprescribing.

Article types accepted by Clinical Pharmacist include research, reviews, perspectives, insight, CPD and short communications (for more information refer to our author guidelines).

Technical information

Clinical Pharmacist provides credible, authoritative and high-quality resources on the clinical management of disease in relation to medicines and up-to-date information about advances in pharmacy and drug development.

Articles and ideas for potential articles should be submitted by email to [email protected], with a cover letter explaining the importance of the work for the audience and clearly stating that the submission is in response to this call. All articles must be received by January 2019.

It is envisaged that articles submitted in response to this call and accepted for publication will be published under a ‘Special Report’ on www.jizak.info.

 

Nigel Praities, executive editor, and Michael Dowdall, senior editor, research and learning, at Pharmaceutical Journal Publications

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205544

Readers' comments (1)

  • About time too!
    I am a complex needs type 2 diabetic on insulin, I also have had a pacemaker for 15 years as a consequence of being unable tolerate Metformin. Did it put me into Heart failure?
    While on Metformin I also developed a tingling sensation in my legs and feet though discussed with at least four consultants over the years it was not until by chance I read an article on Vitamin B12 and on checking my medications a blood test revealed a deficiency.
    It is remarkable that this is a repeat of the same scenario to years ago in respect of Vitamin D.
    As the Patient I am in their hands. Why are not blood tests ordered at the time as medication is prescribed and a continuing regime established?

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £133.00
  • BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £252.00
  • International Research in Healthcare

    Guidance for students or researchers undertaking a multi-centre research project in health services, medicines use and professional practice.

    £38.00
  • Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £43.00
  • Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.